The outcomes of more than 4300 women treated by pharmacists in the controversial Queensland UTI prescribing trial are unknown, according to a draft version of the State Government’s own evaluation.

The Australian newspaper said yesterday it had obtained a 126-page evaluation report written by Professor Lisa Nissen from the school of clinical sciences at Queensland University of Technology. 

Under the trial, 6750 patients paid pharmacists $19.95 to diagnose uncomplicated UTIs, with treatment options including trimethoprim, nitrofurantoin or cefalexin dispensed as private scripts.

However, only 36% were successfully contacted for follow up under the evaluation, The Australian said.